Wave Life Sciences (WVE) Current Deferred Tax Assets (2014 - 2016)
Wave Life Sciences' (WVE) quarterly Current Deferred Tax Assets came in at $214000.0 in Q4 2016, up 1088.89% YoY from $18000.0 in Q1 2016, and up 830.43% on a QoQ basis from $23000.0 in Q1 2016.
Wave Life Sciences (WVE) Current Deferred Tax Assets (2014 - 2016) Analysis & Trends
Wave Life Sciences (WVE) has 3 years of Current Deferred Tax Assets data on file, last reported at $214000.0 in Q4 2016.
- Quarterly Current Deferred Tax Assets rose 1088.89% year-over-year to $214000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $214000.0 (up 1088.89% YoY) and the FY2016 annual result came in at $214000.0, up 1088.89% from the prior year.
- Current Deferred Tax Assets rose to $214000.0 in Q4 2016, from $23000.0 in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $214000.0 in Q4 2016 to a low of $18000.0 in Q4 2015.
- A 3-year average of $76600.0 and a median of $64000.0 in 2014 frame the typical range for Current Deferred Tax Assets.
- Annual changes were most pronounced in 2015 — Current Deferred Tax Assets tumbled 71.88% — and 2016, when it soared 1088.89%.
- Tracing WVE's Current Deferred Tax Assets over 3 years: stood at $64000.0 in 2014, then plunged by 71.88% to $18000.0 in 2015, then soared by 1088.89% to $214000.0 in 2016.
- The last three Current Deferred Tax Assets figures came in at $214000.0 (Q4 2016), $23000.0 (Q1 2016), and $18000.0 (Q4 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 214,000.00 |
| Dec 31, 2016 | 214,000.00 |
| Mar 31, 2016 | 23,000.00 |
| Mar 31, 2016 | 23,000.00 |
| Dec 31, 2015 | 18,000.00 |
| Dec 31, 2015 | 18,000.00 |
| Sep 30, 2015 | 64,000.00 |
| Sep 30, 2015 | 64,000.00 |
| Dec 31, 2014 | 64,000.00 |
| Dec 31, 2014 | 64,000.00 |